Late follow-up of a randomized trial of surgery plus tamoxifen <i>versus</i> tamoxifen alone in women aged over 70 years with operable breast cancer

Abstract

Omission of primary surgery in unselected elderly women with operable breast cancer who were fit for the procedure resulted in an increased rate of progression, therapeutic intervention and mortality.